Gold and Silver Prices Fluctuate as Middle East Tensions and Strong Dollar Drive Uncertainty Trump Pressures Bank of America JPMorgan Over Alleged Conservative Discrimination L3Harris Technologies Stock Wall Street Weighs Bullish Defense Outlook Against Valuation Concerns BTS Secures Top American Music Awards Honor for Second Consecutive Year Healthcare and Tech Lead SP 500 to Modest Gains Communication Services Lags Silicon Valley Turns to Mundane Businesses AI and Dealmaking Reshape Accounting Property Management OMAB Q1 2026 Earnings EPS Misses Estimates Shares Decline Horizon Bancorp Inc HBNC Q1 2026 Earnings EPS Beats Estimates Despite Modest Share Declines Enel Chile Q4 2025 Earnings EPS Beats Estimates by 281 Amidst Operational Resilience BTCS Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Company Faces Headwinds Ulta Beauty Q1 2026 Earnings EPS Misses Estimates Amid Challenging Beauty Retail Environment MU Q1 2026 Earnings Strong EPS Beat Driven by AI Memory Demand Stock Falls 146 GoHealth Inc GOCO Surges 744 as Buyers Defend Key Support Near 066 Udemy Inc UDMY Stabilizes Near Support as Market Awaits Catalyst BRC Inc BRCC Declines 257 as Shares Approach Key Support Level Helmerich Payne HP Posts Modest Gain Key Levels in Focus Pilgrims Pride PPC Edges Lower Amid Sector Pressure Holding Above Key Support Chunghwa Telecom Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower Standex International SXI Q1 2026 Earnings EPS Misses Estimates but Shares Edge Higher ABCL Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction POET Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage Brookfield Asset Management Inc BAM Q1 2026 Earnings Slight EPS Miss Amid Stable Operations AirJoule Technologies Q1 2026 Earnings Significant EPS Miss Amid Development Stage Stock Rises on Strategic Hopes Professional Title AIDriven Hiring Doom Loop JobSeekers and Recruiters in an Arms Race of Homogenized Applications Pegasystems Q1 2026 Earnings EPS Misses Estimates as Profitability Pressures Emerge Propanc Biopharma PPCB Slides 69 as Weak Momentum Tests Key Support